Clinical trials
Brain Injuries, Traumatic trials in Denmark
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 1 |
| 2017 | 5 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 2 |
| 2024 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Unknown status | 3 |
| Recruiting | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Aarhus | 9 |
| Rigshospitalet, Denmark | 5 |
| Christina Kruuse | 1 |
| Danish Research Centre for Magnetic Resonance | 1 |
| JFK Medical Center | 1 |
| Jens Rikardt Andersen | 1 |
| NeuroVive Pharmaceutical AB | 1 |
| University Hospital, Antwerp | 1 |
| University Hospital, Gentofte, Copenhagen | 1 |
| University of Southern Denmark | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Brain Injuries, Traumatic | 22 |
| Brain Injuries | 8 |
| Subarachnoid Hemorrhage | 5 |
| Consciousness Disorders | 4 |
| Craniocerebral Trauma | 4 |
| Hypoxia-Ischemia, Brain | 4 |
| Stroke | 4 |
| Cerebral Hemorrhage | 2 |
| Glioblastoma | 2 |
| Margins of Excision | 2 |
Trials
Showing 51 to 22 of 22. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.